Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling;Optikusatrophie nach epiretinalen triamcinolon-ablagerungen in einem auge mit entfernter membrana limitans interna

Ophthalmologe

Volumn 105, Issue 6, 2008, Pages 575-577

  Jaissle, G B ^a   Bartz Schmidt, K U ^a   Szurman, P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Epiretinal deposit; Optic nerve atrophy; Toxicity; Triamcinolone; Visual field defect

Indexed keywords

EID: 46449101828     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-007-1620-z     Document Type: Article

References (13)

1. Fraser EA, Cheema RA, Roberts MA (2003) Triamcinolone acetonide-assisted peeling of retinal internal limiting membrane for macular surgery. Retina 23: 883-884
2. Jaissle GB, Szurman P, Bartz-Schmidt KU (2004) Nebenwirkungen und Komplikationen bei der intravitrealen Triamcinolonacetonid-Therapie. Ophthalmologe 101: 121-128
3. Jaissle GB, Szurman P, Völker M, Bartz-Schmidt KU (2007) Epiretinal deposit of triamcinolone acetonide at the posterior pole after intravitreal injection. Ophthalmic Surg Lasers Imaging 38: 238-241
4. Miolo G, Ricci A, Caffieri S (2003) In vitro phototoxic properties of triamcinolone 16,17-acetonide and its main photoproducts. Photochem Photobiol 78: 425-430
5. Modarres M, Parvaresh MM, Peyman GA (1998) Accidental subretinal injection of triamcinolone acetonid. Ophthalmic Surg Lasers 29: 935-938
6. Nakamura T, Murata T, Hisatomi T et al. (2003) Ultrastructure of the vitreoretinal interface following the removal of the internal limiting membrane using indocyanine green. Curr Eye Res 27: 395-399
7. Saikia P, Maisch T, Kobuch K et al. (2006) Safety testing of indocyanine green in an ex vivo porcine retina model. Invest Ophthalmol Vis Sci 47: 4998-5003
8. Satofuka S, Inoue M, Shinoda K et al. (2005) Adherence of intravitreally injected triamcinolone acetonide to the denuded retinal surface after internal limiting membrane peeling. Retina 25: 672-673
9. Shaikh S, Ho S, Engelmann LA, Klemann SW (2006) Cell viability effects of triamcinolone acetonide and preservative vehicle formulations. Br J Ophthalmol 90: 233-236
10. Szurman P, Kaczmarek R, Spitzer MS et al. (2006) Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Exp Eye Res 83: 584-592
11. Szurman P, Sierra A, Kaczmarek R et al. (2007) Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res 85: 44-53
12. Yeung CK, Chan KP, Chiang SWY et al. (2003) The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 44: 5293-5300
13. Yu SY, Damico FM, Viola F et al. (2006) Retinal toxicity of intravitreal triamcinolone acetonide. A morphological study. Retina 26: 531-536